1er juin

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 02:00
  Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction JAMA Cardiology
  This post hoc analysis of A Study to Evaluate the Corvia Medical Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF II) randomized clinical trial evaluates the long-term effects of an atrial shunt device on cardiac structure and function in (…)
• 02:00
  Clopidogrel Monotherapy for Double-Risk Acute Coronary Syndrome JAMA Cardiology
  In this issue of JAMA Cardiology, Li et al report the results of the double-blind, placebo-controlled Optimal Antiplatelet Therapy for High Bleeding and Ischemic Risk Patients (OPT-BIRISK) trial, which randomized 7758 patients with acute coronary syndrome (ACS) after percutaneous coronary (…)
• 02:00
  Need for More Data About Atrial Fibrillation Ablation in Heart Failure JAMA Cardiology
  Atrial fibrillation (AF) and heart failure (HF) coexist in a syndemic relationship, characterized by a similar epidemiology and exacerbated pathological outcomes, often intensified by social drivers of health. The 2023 ACC/AHA/ACCP/HRS Guidelines for the Diagnosis and Management of Atrial (…)
• 02:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (…)
• 02:00
  Error in Table 1 JAMA Cardiology
  The Original Investigation titled “Emphasizing Sexual Orientation and Gender Identity Data Capture for Improved Cardiovascular Care of the LGBTQ+ Population,” published online January 24, 2024, and in the March 2024 issue of JAMA Cardiology, was corrected to fix an error in the categorization of (…)
• 02:00
  A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and Progression JAMA Cardiology
  This cohort study explores whether a novel artificial intelligence (AI) video-based biomarker for aortic stenosis is associated with development and progression of aortic stenosis.
• 02:00
  Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1 JAMA Cardiology
  This cohort study investigates the association of clonal hematopoiesis of indeterminate potential with risk for atrial fibrillation.
• 02:00
  Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease JAMA Cardiology
  This secondary analysis of a randomized clinical trial examines the antibody response to high-dose trivalent compared with standard-dose quadrivalent inactivated influenza vaccine in patients with a recent acute myocardial infarction or heart failure hospitalization.
• 02:00
  Clopidogrel vs DAPT in Acute Coronary Syndromes and High Ischemic/Bleeding Risk JAMA Cardiology
  This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.
• 02:00
  Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome) JAMA Cardiology
  This case report discusses a diagnosis of Leriche syndrome in a male patient with peripheral arterial disease, erectile dysfunction, and nonischemic cardiomyopathy.
• 02:00
  Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021 JAMA Cardiology
  This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
• 02:00
  Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction JAMA Cardiology
  This systematic review and meta-analysis investigates the efficacy of catheter ablation compared with rate or rhythm control among patients with atrial fibrillation and heart failure.
• 02:00
  Fontan Junctional Rhythm JAMA Cardiology
  This Viewpoint discusses the impact of sinus node dysfunction and escape junctional rhythm associated with the Fontan procedure on patient outcomes.
• 02:00
  Deep Learning–Based Assessment of Built Environment From Satellite Images and Cardiometabolic Disease Prevalence JAMA Cardiology
  This cross-sectional study investigates the association between cardiometabolic disease prevalence in the US and deep learning–based assessment of the built environment from satellite imagery.
• 02:00
  Wide Complex Tachycardia in a Middle-Aged Woman With Diarrhea JAMA Cardiology
  A woman in her mid-60s with a history of paroxysmal atrial fibrillation and hypertension presents with 3 days of nausea, vomiting, and diarrhea. What would you do next?
• 02:00
  Complete vs Culprit-Only Revascularization in Older Patients With MI and High Bleeding Risk JAMA Cardiology
  This randomized clinical trial investigates if patients with high bleeding risk and a history of myocardial infarction (MI) would benefit from complete vs culprit-only revascularization.
• 02:00
  Underrepresentation of Women in Revascularization Trials JAMA Cardiology
  This Viewpoint discusses the unequal representation of women in coronary revascularization trials in the US, its negative effects on the cardiovascular health of both sexes, and potential mechanisms to ensure appropriate representation of women moving forward.

8 mai

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 02:00
  JAMA Cardiology Peer Reviewers in 2023 JAMA Cardiology
  We sincerely thank the 670 peer reviewers who completed manuscript reviews for JAMA Cardiology in 2023.

1er mai

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 02:00
  Ticagrelor or Clopidogrel Monotherapy vs DAPT After PCI JAMA Cardiology
  This systematic review and individual patient data meta-analysis assesses the risks and benefits of ticagrelor monotherapy or clopidogrel monotherapy compared with standard dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI).
• 02:00
  Type 2 Myocardial Infarction—Poorly Understood, Underevaluated, and Too Often Ignored JAMA Cardiology
  This Viewpoint discusses diagnosis of type 2 myocardial infarction.
• 02:00
  Moving Beyond Conventional Guesstimation to Guide PCI JAMA Cardiology
  Despite widespread availability of adjunctive tools beyond angiography that improve the accuracy and precision of coronary stenosis assessment, current percutaneous coronary intervention (PCI) is still usually performed using subjective visual estimations of the coronary angiogram: essentially (...)
• 02:00
  What’s VAT All About—The Clue is in the Genetics JAMA Cardiology
  White adipose tissue (WAT) is responsible for energy storage. WAT is subdivided into subcutaneous adipose tissue (SAT, approximately 80%-90% of total AT) and visceral adipose tissue (VAT), the latter of which includes both ectopic thoracic and abdominal depots.
• 02:00
  Quantitative Coronary Angiography vs Intravascular Ultrasonography to Guide Drug-Eluting Stent Implantation JAMA Cardiology
  This randomized clinical trial compares 12-month event rates using quantitative coronary angiography guidance during percutaneous coronary intervention with those after intravascular ultrasonography–guided stent implantation.
• 02:00
  Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity JAMA Cardiology
  This cohort study investigates the cardiovascular disease associations and genetic determinants of epicardial and pericardial adiposity.
• 02:00
  Change to Open Access Status JAMA Cardiology
  The Original Investigation titled “Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial,” published online February 21, 2024, was changed to open access status under a CC-BY license. This article (...)
• 02:00
  Open Access Note Added to Article Information JAMA Cardiology
  In the Original Investigation titled “Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection,” published in the December 2023 issue of JAMA Cardiology, CC-BY-NC-ND open access license information has now been added to the Article Information section of (...)
• 02:00
  Electrocardiographic Findings in Female Professional Basketball Athletes JAMA Cardiology
  This cross-sectional study describes reference ranges for electrocardiography findings among female professional basketball athletes.
• 02:00
  JAMA Cardiology —The Year in Review, 2023 JAMA Cardiology
  JAMA Cardiology completed another successful year in 2023 in which we maintained our position among the top journals in the field of cardiovascular medicine. After 8 years of publishing, JAMA Cardiology’s journal impact factor was 24.0 in 2023 (reported for the year 2022). Our weekly content (...)
• 02:00
  Consolidating NRMP Fellowship Matches to Enhance the Applicant Experience JAMA Cardiology
  To the Editor The National Resident Matching Program (NRMP) appreciates the perspective shared by Bravo-Jaimes in her recent From the Heart commentary. In 2019, she and her spouse participated in different matches within the NRMP Specialties Matching Service. For the NRMP to leverage the (...)
• 02:00
  Risk of Cardiac Arrhythmias Among Climbers on Mount Everest JAMA Cardiology
  This cohort study examines data from climbers at Mount Everest to explore the incidence of tachyarrhythmias and bradyarrhythmias in healthy individuals at high altitudes.
• 02:00
  Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction JAMA Cardiology
  This case report discusses a diagnosis of spontaneous coronary artery dissection in an otherwise healthy man with non–ST elevation myocardial infarction.
• 02:00
  Intravascular Imaging–Guided Optimization of Complex Percutaneous Coronary Intervention by Sex JAMA Cardiology
  This prespecified subanalysis of the RENOVATE-COMPLEX-PCI trial evaluates potential differences in outcomes with intravascular imaging–guided percutaneous coronary intervention of complex coronary artery lesions between women and men.
• 02:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)
• 02:00
  In Memoriam—William H. Gaasch, MD, 1937-2022 JAMA Cardiology
  He was a man, take him for all in all,I shall not look upon his like again.William Shakespeare, Hamlet
• 02:00
  A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I JAMA Cardiology
  This diagnostic study aims to develop and validate a simple new criterion, time to notch longer than 75 milliseconds in lead I on electrocardiography, to identify left bundle branch block based on electrophysiological studies of human patients.
• 02:00
  Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction JAMA Cardiology
  This prognostic study investigates if models that incorporate routinely collected clinical and laboratory information can predict morbidity and mortality in patients with heart failure and preserved ejection fraction.

1er avril

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 02:00
  ?-Blocker Withdrawal and Functional Capacity Improvement in Patients With HFpEF JAMA Cardiology
  This study attempts assess to the association of ?-blocker treatment withdrawal on changes in the percentage of predicted peak oxygen consumption across indexed left ventricular diastolic and systolic volumes, and left ventricular ejection fraction in patients with heart failure with preserved (...)
• 02:00
  Transient Monocular Blindness in a Man in His 30s JAMA Cardiology
  This case report discusses a diagnosis of giant ascending aortic aneurysm in a patient who presented with transient monocular blindness and no cardiovascular symptoms.
• 02:00
  Deep Learning–Augmented ECG Screening and Genotype Prediction of Congenital Long QT Syndrome JAMA Cardiology
  This diagnostic accuracy study examines whether deep learning models using 12-lead electrocardiography (ECG) can improve the detection of congenital long QT syndrome (LQTS) and differentiate between LQTS genotypes.
• 02:00
  Statins, Inflammation, and Tissue Context in REPRIEVE JAMA Cardiology
  Inflammation is a central cause and byproduct of atherosclerosis. Within the broader umbrella of inflammation, there exists meaningful heterogeneity in triggers, cellular effectors, and tissue context. Lipid-related inflammation plays a critical role, as apolipoprotein B (ApoB)–containing (...)
• 02:00
  Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV JAMA Cardiology
  This substudy of a randomized clinical trial investigates the effects of pitavastatin on noncalcified coronary artery plaque using coronary computed tomography angiography and on inflammatory biomarkers as potential mechanisms for major adverse cardiovascular event prevention.
• 02:00
  Physical Activity, Sedentary Time, and Heart Failure Risk in Older Women JAMA Cardiology
  This cohort study investigates the association of accelerometer-measured physical activity and sedentary behavior with incident heart failure in older women.
• 02:00
  Interventions for Optimization of Guideline-Directed Medical Therapy JAMA Cardiology
  This study performs a systematic review to identify which types of system-level initiatives are most effective at improving guideline-directed medical therapy use among patients with heart failure with reduced ejection fraction.
• 02:00
  Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations JAMA Cardiology
  This cohort study uses data from 3 populations to assess whether lipoprotein(a) levels are associated with cardiovascular risk independent of high-sensitivity C-reactive protein level.
• 02:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)
• 02:00
  A Female in Her 50s With Caseating Mitral Annulus Calcification JAMA Cardiology
  This case report describes a diagnosis of caseating mitral annulus calcification in a female patient with a history of peritoneal dialysis who presented with confusion and disorientation.
• 02:00
  Age and Computed Tomography and Invasive Coronary Angiography in Stable Chest Pain JAMA Cardiology
  This prespecified secondary analysis of the Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) randomized clinical trial investigates the association of age with clinical outcomes after computed tomography and coronary (...)
• 02:00
  Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis JAMA Cardiology
  This cohort study evaluates a novel polygenic risk score for estimating risk of aortic stenosis compared with the use of established risk factors.
• 02:00
  Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis JAMA Cardiology
  This cohort study examines the use of cardiopulmonary exercise testing in evaluating patients with transthyretin amyloidosis.
• 02:00
  Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia JAMA Cardiology
  This cohort study evaluates sex differences in age at diagnosis, risk factors, treatment, and cardiovascular morbidity and mortality in patients with homozygous familial hypercholesterolemia.

1er mars

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 01:00
  Precision Medicine for Hypertensive Disorders of Pregnancy—Are We There Yet? JAMA Cardiology
  New-onset hypertensive disorders of pregnancy (HDPs) are a heterogeneous syndrome of interrelated vascular conditions. HDPs include gestational hypertension, preeclampsia, and eclampsia and are defined by elevated blood pressure (BP) beginning after 20 weeks’ gestation with or without (...)
• 01:00
  Genetic Associations of Circulating Cardiovascular Proteins With Gestational Hypertension and Preeclampsia JAMA Cardiology
  This genetic association study investigates if mendelian randomization can identify associations between circulating cardiovascular disease–related proteins and hypertensive disorders of pregnancy.
• 01:00
  Bundled Payments for Care Improvement and Quality of Care and Outcomes in Heart Failure JAMA Cardiology
  This cross-sectional study examines outcomes for patients hospitalized with heart failure to compare changes in the quality and outcomes of care according to hospital participation in the Medicare Bundled Payments for Care Improvement program.
• 01:00
  Somatic and Germline Variants and Coronary Heart Disease JAMA Cardiology
  This cohort study examines data for participants from 3 prospective cohorts in China to target genetic mutations associated with clonal hematopoiesis of indeterminate potential and estimate the risk of incident coronary heart disease in carriers.
• 01:00
  Private Equity and Cardiovascular Health Care JAMA Cardiology
  This Viewpoint discusses involvement of private equity firms in health care.
• 01:00
  Cardiac Perforation After Pacemaker Placement in a Male Patient in His 80s JAMA Cardiology
  This case report describes a diagnosis of cardiac perforation secondary to pacemaker placement in a male patient in his 80s who presented with pulsing chest pain.
• 01:00
  Clonal Hematopoiesis and Coronary Artery Disease—A Deep Connection JAMA Cardiology
  Clonal hematopoiesis, often referred to as clonal hematopoiesis of indeterminate potential (CHIP), is gaining recognition as an important and independent risk factor for atherosclerotic cardiovascular disease (ASCVD). This condition results from the acquisition of certain somatic mutations in (...)
• 01:00
  Precision Measurement of Telomere Length as a Future Guide to Improve CVD Interventions JAMA Cardiology
  To the Editor Progressive telomere shortening is an aging hallmark, and aberrant telomere attrition predicts aging-related diseases and mortality in the general population. In previous studies, shorter leukocyte telomere length (LTL) was associated with increased risk of adverse cardiovascular (...)
• 01:00
  Impact of Bempedoic Acid on Total Cardiovascular Events JAMA Cardiology
  This prespecified analysis of the Cholesterol Lowering via Bempedoic Acid, an ATP Citrate Lyase (ACL)–Inhibiting Regimen (CLEAR) Outcomes trial investigates if bempedoic acid is associated with a reduction in the total burden of cardiovascular events in patients at high risk for cardiovascular (...)
• 01:00
  Polygenic Risk in Families With Spontaneous Coronary Artery Dissection JAMA Cardiology
  This genetic association study evaluates the contribution of rare and common genetic variants to spontaneous coronary artery dissection risk in familial cases, the latter via the comparison of a polygenic risk score with those with sporadic spontaneous coronary artery dissection and healthy (...)
• 01:00
  Sexual Orientation and Gender Identity Data Capture in Cardiovascular Care JAMA Cardiology
  This Special Communication discusses the advancement of cardiovascular health equity for the lesbian, gay, bisexual, transgender, and queer patient population through careful and accurate collection of sexual orientation and gender identity and expression data.
• 01:00
  A Female Patient With Recurrent Headache and Syncope JAMA Cardiology
  This case report discusses a diagnosis of pulmonary arteriovenous fistulas in a female patient in her 30s who presented with a 5-year history of hypoxia, syncope, and headaches.
• 01:00
  Education and Information to Improve Cardiovascular Health JAMA Cardiology
  To the Editor In the US and Western European countries, cardiovascular disease (CVD)–related mortality rates and burden decreased significantly from 2000 to 2015, but from 2015 to 2019, there was evidence of an inverse trend with plateauing or small increase. This trend toward an increase of (...)
• 01:00
  Education and Information to Improve Cardiovascular Health—Reply JAMA Cardiology
  In Reply We appreciate the letter by Sterpetti and Di Marzo about our SI! Program for Secondary Schools cluster randomized clinical trial carried out in 24 secondary schools and 1326 adolescents in Spain. We agree with the authors on the importance of health education as a tool to improve the (...)
• 01:00
  Advancing Data Collection of Sexual Orientation and Gender Identity in Cardiology JAMA Cardiology
  In cardiovascular disease research and clinical care, comprehensive inclusion of individuals’ sexual orientation and gender identity (SOGI) in population-based and clinical datasets has emerged as a pressing concern. Although extensive research has been dedicated to understanding the (...)
• 01:00
  Complex Genetic Architecture of Spontaneous Coronary Artery Dissection JAMA Cardiology
  Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of nonatherosclerotic myocardial infarction. Clinical risk factors for SCAD include younger age, female sex, pregnancy, and fibromuscular dysplasia. However, these factors remain insufficient for predicting risk (...)
• 01:00
  What Is Your Secret to Health? JAMA Cardiology
  This essay describes how asking a single simple question helps the author understand the factors most important to patients and that could be indirectly considered the secret to their lives’ health, happiness, and longevity.
• 01:00
  Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction JAMA Cardiology
  This post hoc analysis of a randomized clinical trial evaluates the association of dapagliflozin with cause-specific deaths in patients with heart failure with improved ejection fraction.
• 01:00
  Recruiting a Diverse Cardiology Physician Workforce JAMA Cardiology
  This cross-sectional study examines changes in the representation of women and underrepresented individuals in cardiovascular disease and cardiovascular subspecialty fellowships over time.
• 01:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)
• 01:00
  Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol JAMA Cardiology
  This pooled cohort study assesses the risk of coronary heart disease associated with familial hypercholesterolemia variants in individuals with moderately to severely elevated low-density lipoprotein cholesterol.
• 01:00
  Multicenter Validated RVF Risk Score to Predict Right Ventricular Failure After Mechanical Circulatory Support JAMA Cardiology
  This cohort study investigates if patients at risk for right ventricular heart failure after left ventricular assist device implantation can be identified before the implantation procedure is performed.

1er février

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 01:00
  Mineralocorticoid Receptor Antagonism by Eplerenone and Arterial Inflammation in HIV JAMA Cardiology
  This randomized clinical trial investigates if treatment with a mineralocorticoid receptor antagonist reduces arterial inflammation on 18F-fludeoxyglucose–positron emission tomography/computed tomography among persons with HIV.
• 01:00
  Innovation in Event Adjudication—Human vs Machine JAMA Cardiology
  Systematic, standardized, and independent assessment of clinical trial end points is critical to protect the scientific integrity of clinical trials. Clinical event classification (CEC) has become the criterion standard for the process of event adjudication, which includes the creation of end (...)
• 01:00
  Natural Language Processing for Adjudication of Heart Failure JAMA Cardiology
  This secondary analysis of a randomized clinical trial validates the findings of a single-center study regarding the use of natural language processing for the adjudication of heart failure hospitalization.
• 01:00
  Dapagliflozin and eGFR Decline in HFmrEF/HFpEF JAMA Cardiology
  This prespecified analysis of the Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure (DELIVER) randomized clinical trial investigates the association of initial changes in estimated glomerular filtration rate with cardiovascular and kidney (...)
• 01:00
  Neighborhood Environmental Burden and Cardiovascular Health in the US JAMA Cardiology
  This cross-sectional study evaluates associations between environmental burden and cardiovascular risk factors and diseases at the neighborhood level and by levels of social vulnerability.
• 01:00
  Prioritizing the Exposome to Reduce Cardiovascular Disease Burden JAMA Cardiology
  The concept that the totality of environmental exposures, from the prenatal period and throughout life, affect health is termed the exposome, which was coined in 2005 by Wild as a complement to genomics to capture the breadth of environmental exposures on a person’s health risk. Wild argued (...)
• 01:00
  Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission JAMA Cardiology
  This randomized clinical trial evaluates the feasibility and efficacy of an intensive telemonitoring strategy in the vulnerable period after a heart failure hospitalization.
• 01:00
  Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure JAMA Cardiology
  This post hoc analysis of the Torsemide Comparison With Furosemide for Management of Heart Failure (TRANSFORM-HF) randomized clinical trial investigates if torsemide improves mortality and hospitalization outcomes at 12 months compared with furosemide in either de novo heart failure or (...)
• 01:00
  Sudden ST-Segment Changes in a Critically Ill Patient JAMA Cardiology
  A patient in his mid-60s underwent bilateral orthotopic lung transplant and is later hospitalized for sepsis from pneumonia complicated by acute transplant rejection, without any cardiac symptoms. He develops severe acute respiratory distress syndrome requiring intubation and paralysis. (...)
• 01:00
  Female Patient Presenting With Increasing Pedal Edema JAMA Cardiology
  This case report discusses a diagnosis of congenital bicuspid-tricuspid valve in a female patient in their 20s with a history of heart transplant.
• 01:00
  Hypoglycemia and Cardiovascular Outcomes of Linagliptin JAMA Cardiology
  This secondary analysis evaluates antihyperglycemic treatments, hypoglycemic episodes, and risk for cardiovascular events and mortality in 2 randomized clinical trials involving adults with type 2 diabetes.
• 01:00
  Dual Antiplatelet Therapy De-Escalation After Myocardial Infarction With High Ischemic Risk JAMA Cardiology
  This post hoc analysis of the Ticagrelor vs Clopidogrel in Stabilized Patients With Acute Myocardial Infarction (TALOS-AMI) randomized clinical trial investigates the efficacy and safety of the de-escalation strategy of switching from ticagrelor to clopidogrel vs dual antiplatelet therapy with (...)
• 01:00
  Variants at the Interleukin 1 Gene Locus and Pericarditis JAMA Cardiology
  This genome-wide association study reports associations between pericarditis and sequence variants at the interleukin 1 gene locus.
• 01:00
  Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission JAMA Cardiology
  This secondary analysis of the Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by N-Terminal Pro–Brain Natriuretic Peptide Testing of Heart Failure Therapies (STRONG-HF) randomized clinical trial investigates what variables are associated with success in uptitration of (...)
• 01:00
  Lessons From Genetics About the Interleukin 1 Gene and Treatment of Recurrent Pericarditis JAMA Cardiology
  Acute pericarditis is the most common manifestation of pericardial disease and results from inflammation of the fibroelastic lining of the heart. Complications of pericarditis include cardiac tamponade and constrictive pericarditis, both of which are associated with significant morbidity and (...)
• 01:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)
• 01:00
  STRONG-HF Evidence for Proactive, Patient-Centered Prescribing JAMA Cardiology
  Perfection is not attainable, but if we chase perfection we can catch excellence.Vince Lombardi

1er janvier

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 01:00
  The Longest Reported Outcomes of the Ross Procedure JAMA Cardiology
  The ideal aortic valve substitute is accompanied by long durability, avoidance of anticoagulation, and great valvular hemodynamics. Unfortunately, the 2 major choices for valve prostheses, bioprosthetic and mechanical valves, do not fulfill these ideal valve characteristics. In 1967, to (...)
• 01:00
  Long-Term Clinical and Echocardiographic Outcomes After the Ross Procedure JAMA Cardiology
  This post hoc analysis of a randomized clinical trial assesses long-term survival after the Ross procedure among adults.
• 01:00
  Corrected to Open Access Status JAMA Cardiology
  In the Original Investigation titled “Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes,” published online August 30, 2023, the article was corrected to reflect open access status with a CC-BY license. The article was corrected online.
• 01:00
  Mendelian Randomization and Cardiology JAMA Cardiology
  A robust preclinical pipeline of evidence is the ideal prerequisite needed for responsible design and cost-sensitive execution of sometimes multimillion dollar cardiovascular-event–driven randomized clinical trials. Additionally, certain hypotheses don’t sync well, either feasibly or (...)
• 01:00
  Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy JAMA Cardiology
  This post hoc analysis of the randomized Tafamidis in Transthyretin Cardiomyopathy Clinical Trial examines the effect of tafamidis vs placebo on 30-month changes in cardiac function in patients with transthyretin amyloid cardiomyopathy.
• 01:00
  Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk JAMA Cardiology
  This comparative effectiveness study, a prespecified analysis from the MASTER DAPT trial, reports sex differences and the association of sex with outcomes among patients with high bleeding risk treated with an abbreviated vs standard dual antiplatelet therapy regimen.
• 01:00
  High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism JAMA Cardiology
  This cohort study assesses outcomes in patients with pulmonary embolism using high-sensitivity vs conventional troponin I.
• 01:00
  We Matched JAMA Cardiology
  In this essay, the author discusses the importance of a Match system that supports and keeps families together while in training.
• 01:00
  Irregular Rhythm and New-Onset Heart Failure JAMA Cardiology
  A man in his 50s with recurrent palpitations, fatigue, and progressive exertion dyspnea had irregular narrow-QRS tachycardia in an incessant, repetitive fashion with heart rates up to 180 beats per minute and occasional short runs of wide-QRS tachycardia on Holter monitoring and 12-lead (...)
• 01:00
  Swollen Right Upper Limb in a Man in His 60s Undergoing Hemodialysis JAMA Cardiology
  This case report discusses a diagnosis of in-stent thrombus using dual-layer spectral computed tomography with Z-effective images.
• 01:00
  Can Noncalcified Plaques Contribute to Future Coronary Events?—Reply JAMA Cardiology
  In Reply We thank Erbay and colleagues for their interest in our recent work regarding atherosclerotic plaque characterization using coronary 18F-sodium fluoride positron emission tomography. They ask a timely question—does the monitoring of disease activity with target-specific radioligands (...)
• 01:00
  High-Sensitivity Troponin in Pulmonary Embolism Risk Stratification—Proceed With Caution JAMA Cardiology
  High-sensitivity cardiac troponin (hs-cTnI) has transformed the diagnosis and risk stratification of acute myocardial infarction. However, little is known whether detection of low-grade levels of cardiac troponin correlates with outcomes of other conditions, such as pulmonary embolism (PE). (...)
• 01:00
  Can Noncalcified Plaques Contribute to Future Coronary Events? JAMA Cardiology
  To the Editor Moss et al recently published a prospective, international, multicenter longitudinal cohort study of 704 patients with recent myocardial infarction (MI) that investigated whether coronary atherosclerotic plaque activity as assessed by 18F-sodium fluoride positron emission (...)
• 01:00
  Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification JAMA Cardiology
  This cohort study investigates the association between removal of race stratification from the atherosclerotic cardiovascular pooled cohort risk equations and model performance.
• 01:00
  Coronary Artery Spasm During Pulsed Field vs Radiofrequency Catheter Ablation of the Mitral Isthmus JAMA Cardiology
  This cohort study compares the incidence and severity of left circumflex arterial vasospasm between pulsed field ablation and radiofrequency ablation during adjacent ablation along the mitral isthmus.
• 01:00
  Pulsed Field Ablation—Will Coronary Spasm Lead to Iconoclasm? JAMA Cardiology
  Pulsed field ablation (PFA) has emerged as a promising new energy source for cardiac ablation that is relatively selective for cardiac tissue. It involves the delivery of very brief, high-voltage shocks directly to cardiac tissue to create irreversible electroporation and thereby cause cardiac (...)
• 01:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)
• 01:00
  Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction JAMA Cardiology
  Primary prevention guidelines recommend the use of multivariable risk prediction algorithms to assess risk for cardiovascular disease (CVD). However, the tool currently recommended, the pooled cohort equations, includes race. This raises the question: is race really an immutable risk factor (...)
• 01:00
  Educational Attainment and Lifetime Risk of CVD JAMA Cardiology
  This study attempts to calculate lifetime risk estimates of incident cardiovascular disease (CVD) and CVD subtypes and estimate years lived with and without CVD by education.
• 01:00
  Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Stem Transplant JAMA Cardiology
  This study examines the association between clonal hematopoiesis of indeterminate potential and cardiovascular disease in patients with multiple myeloma.
• 01:00
  Mendelian Randomization as a Tool for Cardiovascular Research JAMA Cardiology
  This narrative review describes the strengths, limitations, and applications of mendelian methodology in research.

1er décembre

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 01:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)
• 01:00
  Pulsed Field Closes Gender Gap in Atrial Fibrillation Ablation—Electrifying Insights JAMA Cardiology
  Pulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. Innovations in catheter-ablation technologies and procedural techniques have enhanced PVI durability, with success rates approaching 80% in contemporary randomized studies. Although catheter ablation is the (...)
• 01:00
  Prevalence, Awareness, and Treatment of Elevated LDL Cholesterol in US Adults, 1999-2020 JAMA Cardiology
  This cross-sectional study compares the prevalence, awareness, and treatment of elevated low-density lipoprotein (LDL) cholesterol in US adults in 1999-2000 vs 2017-2020.
• 01:00
  Clinical Outcomes by Sex After Pulsed Field Ablation of Atrial Fibrillation JAMA Cardiology
  This cohort study investigates if patient sex is associated with clinical outcomes of pulsed field ablation for the treatment of individuals with atrial fibrillation.
• 01:00
  Treating Climate and Nature Crisis as a Global Health Emergency JAMA Cardiology
  Over 200 health journals call on the United Nations, political leaders, and health professionals to recognize that climate change and biodiversity loss are one indivisible crisis and must be tackled together to preserve health and avoid catastrophe. This overall environmental crisis is now so (...)
• 01:00
  Driving Medical Innovation—Focusing on the Evidence to Inform Best Care for Patients JAMA Cardiology
  The pace of innovation in medicine has been accelerating with an increasing number of devices being approved by the US Food and Drug Administration (FDA). The 21st Century Cures Act created a breakthrough pathway designation for those devices that provide for more effective treatment or (...)
• 01:00
  Realigning Priorities in the Evaluation and Management of Patients With Heart Failure JAMA Cardiology
  In this issue of JAMA Cardiology, Perera and coauthors report that myocardial viability status has no influence on the outcomes associated with either percutaneous revascularization or optimal medical therapy in patients with heart failure and reduced ejection fraction (HFrEF). An accompanying (...)
• 01:00
  Regulatory Oversight of Cardiovascular Devices—Why We Care JAMA Cardiology
  In this issue of JAMA Cardiology, Moneer and coauthors provide an important perspective outlining the processes by which cardiovascular devices undergo US Food and Drug Administration (FDA) review and receive Medicare reimbursement. The authors highlight the Breakthrough Devices Program, (...)
• 01:00
  Assessment of Myocardial Viability in Ischemic Cardiomyopathy JAMA Cardiology
  Because ischemic cardiomyopathy represents the only form of left ventricular (LV) systolic dysfunction that may derive benefit from coronary artery revascularization, this treatment option—added to guideline-directed medical therapy—is appropriately always considered by clinicians faced with a (...)
• 01:00
  Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients With Heart Failure and Reduced Ejection Fraction JAMA Cardiology
  To the Editor We read with great interest the article by Pierce et al, which found that only 1 in 5 patients hospitalized with heart failure with reduced ejection fraction (HFrEF) in the US was prescribed sodium-glucose cotransporter-2 inhibitor (SGLT2i) at discharge. This is similar to the (...)
• 01:00
  Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients With Heart Failure and Reduced Ejection Fraction—Reply JAMA Cardiology
  In Reply We thank Sadaniantz et al for their interest in our recent article. We agree that our findings suggest concerning disparities in sodium-glucose cotransporter-2 inhibitor (SGLT2i) use in heart failure with reduced ejection fraction (HFrEF) across several demographic and clinical (...)
• 01:00
  Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction JAMA Cardiology
  This secondary analysis of a randomized clinical trial assesses whether myocardial viability testing identifies patients with ischemic left ventricular dysfunction who benefit from percutaneous coronary intervention.
• 01:00
  Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices Program JAMA Cardiology
  This study explores the ways new device authorization and coverage are expedited by the US Food and Drug Administration and Centers for Medicare & Medicaid Services, using examples of devices granted Breakthrough designation, and recommends reforms that both agencies should consider.
• 01:00
  An Elderly Woman With Ventricular Tachycardia JAMA Cardiology
  A woman in her 90s presented to the emergency department with fever, hemoptysis, and syncopal episodes. An electrocardiogram showed monomorphic ventricular tachycardia with a morphology suggesting right ventricular (RV) origin. What would you do next?
• 01:00
  Errors in Abstract and Supplement JAMA Cardiology
  In the Brief Report titled “Effect of Brief Counseling by Allied Health Professionals on Step Count of People With Peripheral Artery Disease: A Randomized Clinical Trial,” published online February 8, 2023, and in the April 2023 issue, there were errors in the Abstract and Supplement. In the (...)
• 01:00
  Identification of Undiagnosed AF in ECGs in Sinus Rhythm JAMA Cardiology
  Unrecognized, undiagnosed atrial fibrillation (AF) is a long-standing and significant public health problem. This is especially the case because ischemic stroke is often the first manifestation of AF. While the rationale for screening for AF to prevent adverse outcomes seems obvious, there are (...)
• 01:00
  Explanation of Error in “Effect of Brief Counseling by Allied Health Professionals on Step Count of People With Peripheral Artery Disease” JAMA Cardiology
  To the Editor During a review of the adverse events in our Brief Behavioral Intervention by Allied Health Professionals to Promote Physical Activity (BIP) trial, we identified that some adverse events were incorrectly classified. We wish to correct the adverse events presented in our published (...)
• 01:00
  Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection JAMA Cardiology
  This cohort study uses Medicare data to assess the number of patients with cardiac implantable electronic device infection who underwent device extraction from 2006 to 2019 and all-cause mortality associated with lead extraction.
• 01:00
  Deep Learning in ECGs in Sinus Rhythm to Predict AF JAMA Cardiology
  This prognostic study investigates whether deep learning models applied to electrocardiograms (ECGs) of sinus rhythm in a population of US Veterans Affairs (VA) patients can predict the presence of concurrent atrial fibrillation (AF).
• 01:00
  Corrected to Open Access Status JAMA Cardiology
  In the Brief Report titled “Representation of Race and Ethnicity in the Contemporary US Health Cohort All of Us Research Program,” published online August 16, 2023, the article was corrected to reflect open access status with a CC-BY license. The article was corrected online.
• 01:00
  Cardio-Oncology Rehabilitation to Improve Care for Cancer Survivors JAMA Cardiology
  The modern-day model of cardiac rehabilitation emerged in the mid-1970s, as the “armchair” treatment of patients after myocardial infarction waned and the benefits of physical activity became more apparent. Supervised cardiac rehabilitation programs, which incorporate exercise, psychosocial (...)
• 01:00
  Concordance of a High Lipoprotein(a) Concentration Among Relatives JAMA Cardiology
  This cross-sectional study measures the association of lipoprotein(a) concentrations in pairs of first- and second-degree relatives of participants in the UK Biobank with high lipoprotein(a) levels.
• 01:00
  Cardio-Oncology Rehabilitation for Cancer Survivors With High Cardiovascular Risk JAMA Cardiology
  This randomized clinical trial compares fitness improvements and control of cardiovascular risk factors among cancer survivors with cardiovascular disease and/or exposure to cardiotoxic cancer treatment who underwent center-based cardiac rehabilitation or usual care with community-based (...)

1er novembre

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 01:00
  Error in Author Name JAMA Cardiology
  In the Review titled “Deep Learning for Cardiovascular Imaging: A Review,” published Online First on September 20, 2023, an author’s surname was misspelled in the byline. The name of the second author is Aggelos K. Katsaggelos, PhD. This article was corrected online.
• 01:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)
• 01:00
  Mitochondrial Respiration and Exercise Performance in Heart Failure With Preserved Ejection Fraction JAMA Cardiology
  To the Editor We read with great interest the insightful study by Scandalis et al showing that patients with heart failure with preserved ejection fraction (HFpEF) have profound reductions in ex vivo skeletal muscle mitochondrial respiration especially with respect to maximal capacity, complex (...)
• 01:00
  Mitochondrial Respiration and Exercise Performance in Heart Failure With Preserved Ejection Fraction JAMA Cardiology
  To the Editor We read with great interest the excellent article by Scandalis et al on dysfunction of skeletal muscle mitochondria in patients with heart failure with preserved ejection fraction (HFpEF). The authors demonstrate a significant association between maximal mitochondrial respiratory (...)
• 01:00
  Mitochondrial Respiration and Exercise Performance in Heart Failure With Preserved Ejection Fraction—Reply JAMA Cardiology
  In Reply We appreciate the Letters to the Editor by Burtscher and Burtscher as well as by Abu-Own et al about our article. We would like to address their key comments.
• 01:00
  Role of Posterior Wall Isolation in Catheter Ablation in Persistent AF Fibrillation and Systolic HF JAMA Cardiology
  This secondary analysis of a randomized clinical trial examines whether adding posterior wall isolation to pulmonary vein isolation improves outcomes in patients with heart failure (HF) with reduced ejection fraction and atrial fibrillation (AF).
• 01:00
  Economic Evaluation of Angiotensin-Neprilysin Inhibitors JAMA Cardiology
  One challenge to the use of novel pharmaceutical treatments for heart failure (HF) is that they are more efficacious in individuals with HF with reduced ejection fraction (HFrEF; left ventricular ejection fraction [LVEF], ?40%) than those with midrange EF (HFmEF; LVEF, 41%-49%) and HF with (...)
• 01:00
  Economic Evaluation of Sacubitril-Valsartan JAMA Cardiology
  This economic evaluation examines the cost-effectiveness of sacubitril-valsartan among a range of ejection fractions and at different upper-level cutoffs of below-normal ejection fractions.
• 01:00
  Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020 JAMA Cardiology
  This cohort study investigates the prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, using data from the National Health and Nutrition Examination Survey.
• 01:00
  Tyranny of the Rules JAMA Cardiology
  This essay describes the author’s experience with the application of medical guidelines in the treatment of patients.
• 01:00
  Repurposing Mirabegron in Patients With Structural Cardiac Disease JAMA Cardiology
  This randomized clinical trial evaluates repurposing mirabegron, a ?3-adrenergic receptor agonist, to prevent progression of left ventricular hypertrophy and diastolic dysfunction among patients with pre- or mild heart failure.
• 01:00
  Deep Learning for Cardiovascular Imaging JAMA Cardiology
  This narrative review describes the potential for artificial intelligence applications to reduce technical burden and improve efficiency in cardiovascular imaging and explains the challenges in the development and implementation of deep learning systems.
• 01:00
  Woman in Her 50s With an Intravenous Mass Extending to the Right Cardiac Chamber JAMA Cardiology
  This case report describes a diagnosis of intravenous leiomyomatosis in a woman in her 50s who presented with exertional dyspnea and syncope and had a history of hysteromyomectomy.
• 01:00
  Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease JAMA Cardiology
  This post hoc secondary analysis of a randomized clinical trial compares the effectiveness and safety of enteric-coated aspirin vs uncoated aspirin among patients with atherosclerotic cardiovascular disease.
• 01:00
  Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction? JAMA Cardiology
  This Viewpoint discusses palliative care for patients with heart failure with preserved ejection fraction.
• 01:00
  Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia JAMA Cardiology
  This randomized clinical trial investigates if evinacumab provides a sustained reduction in low-density lipoprotein cholesterol level in patients with hypercholesterolemia refractory to maximum-tolerated combinations of currently available lipid-lowering therapies.
• 01:00
  Fractional Flow Reserve–Negative High-Risk Plaques in MI JAMA Cardiology
  This cohort study assesses the association between optical coherence tomography (OCT)-detected, fractional flow reserve (FFR)-negative nonculprit lesions and adverse cardiovascular events in patients with myocardial infarction (MI).
• 01:00
  Long-Term Quality of Life After Out-of-Hospital Cardiac Arrest JAMA Cardiology
  This survey study uses standardized patient-reported outcome measures to determine the long-term quality of life of survivors of out-of-hospital cardiac arrest in Denmark.
• 01:00
  Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy JAMA Cardiology
  This randomized clinical trial assesses the role of valsartan in modification of disease progression and characterizes short-term phenotypic progression among sarcomere variant carriers with subclinical hypertrophic cardiomyopathy.
• 01:00
  Reducing the Risks of Nuclear War—The Role of Health Professionals JAMA Cardiology
  In January 2023, the Science and Security Board of the Bulletin of the Atomic Scientists moved the hands of the Doomsday Clock forward to 90 seconds before midnight, reflecting the growing risk of nuclear war. In August 2022, the UN Secretary-General António Guterres warned that the world is (...)
• 01:00
  Medical Editors vs Nuclear Weapons JAMA Cardiology
  As humanity struggles with multiple existential threats, it is marvelous to see the editors of leading medical journals of the world united in a prescription to reduce the threat of nuclear war. This advice is timely, as the ongoing war in Ukraine poses a risk of uncontrollable escalation to (...)

1er octobre

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 02:00
  JAMA Network Call for Papers on Health and the 2024 US Election JAMA Cardiology
  Nationally and globally, health will continue to be one of the most important policy issues for the 2024 US election. Information about these health issues is critical for decision-making and to answer pressing public and global health questions affecting the US and the world. US elections are (...)
• 02:00
  Use the Receiver Operating Characteristic to Assess Model Accuracy JAMA Cardiology
  To the Editor Wang et al examined the ability of the receiver operating characteristic (ROC), which assesses discrimination (order of predictions) but not calibration (how close the predictions are to the observed value), to assess a model’s predictive accuracy. They concluded that the ROC (...)
• 02:00
  Use the Receiver Operating Characteristic to Assess Model Accuracy—Reply JAMA Cardiology
  In Reply We thank Dr Burke for the comments on our article. We acknowledge that C statistics are unit-free and thus do not directly depend on the underlying time scale of the data, while the mean absolute difference (MAD) intrinsically depends on the time scale. However, we do not view this as (...)
• 02:00
  Recommendations for Deferred Testing in Low-Risk Chest Pain JAMA Cardiology
  In JAMA Cardiology, Udelson et al describe a prespecified substudy of the Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (PRECISE), which is the subject of a separate article also published in JAMA Cardiology. This rigorously designed substudy (...)
• 02:00
  Risk-Based Testing vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease JAMA Cardiology
  This randomized clinical trial investigates the optimal initial evaluation pathway to reduce unnecessary testing referral for patients with suspected coronary artery disease who are symptomatic but in stable condition.
• 02:00
  Deferred Testing in Stable Outpatients With Suspected CAD JAMA Cardiology
  This study assesses process of care and health outcomes in people identified as minimal risk for coronary artery disease when testing is deferred.
• 02:00
  From Clinical Trials to Clinical Practice—Frailty-Guided Management of Cardiovascular Disease JAMA Cardiology
  This Viewpoint discusses pitfalls in measurement and interpretation of post hoc frailty scores and proposes standardized frailty assessment in randomized clinical trials.
• 02:00
  Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy JAMA Cardiology
  Cardiac myosin inhibitors are a novel class of drugs developed to target the underlying molecular defect of hyperactivation of the cardiac sarcomere in patients with hypertrophic cardiomyopathy (HCM). The first in class, mavacamten, received US Food and Drug Administration (FDA) approval in (...)
• 02:00
  Mavacamten for Obstructive Hypertrophic Cardiomyopathy in China JAMA Cardiology
  Once new science rolls over, if you’re not part of the steamroller, you become part of the road.Adaptation of a quote by Stewart Brand
• 02:00
  Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy JAMA Cardiology
  This randomized clinical trial evaluates the safety and efficacy of mavacamten compared with placebo for Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy.
• 02:00
  Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction JAMA Cardiology
  This randomized clinical trial investigates the long-term efficacy of mavacamten in reducing the need for septal reduction therapy in patients with obstructive hypertrophic cardiomyopathy.
• 02:00
  Health Claims and Doses of Fish Oil Supplements in the US JAMA Cardiology
  This cross-sectional study investigates the health claims made on the labels of fish oil supplements and the total daily dose of eicosapentaenoic acid and docosahexaenoic acid in commonly available fish oil supplements.
• 02:00
  Coronary Venous Pressure and Microvascular Hemodynamics in Patients With Microvascular Angina JAMA Cardiology
  This randomized clinical trial investigates the effect of coronary venous pressure on myocardial resistances in patients with microvascular disease.
• 02:00
  Defining a Precise Diagnostic Strategy for Suspected Coronary Artery Disease—Lessons Learned From the PRECISE Trial JAMA Cardiology
  In the world of noninvasive imaging, there has been considerable controversy as to which is the better initial diagnostic procedure for evaluation of suspected coronary artery disease (CAD)—a test for ischemia or anatomy. The ischemia-guided strategy is the most common diagnostic approach (...)
• 02:00
  Linking Kidney Vessel Scarring to Cardiovascular Risk—Reply JAMA Cardiology
  In Reply We appreciate the comments provided by d’Izarny-Gargas et al in their Letter to the Editor responding to our study of kidney histopathologic lesions and incident cardiovascular disease (CVD) or death. We address their questions here.
• 02:00
  Erroneous Rapid Exchange Balloon Inflation During Coronary Angioplasty in a Male Patient in His 70s With Chronic Stable Angina JAMA Cardiology
  This case report discusses an erroneous rapid exchange balloon inflation during coronary angioplasty in a patient who presented with a right coronary artery lesion on angiography.
• 02:00
  Adverse Childhood Experiences as Social Determinants of Cardiovascular Health JAMA Cardiology
  As editors for JAMA Cardiology, we endorse a recurring investigatory theme of the importance of upstream social determinants of health (SDOH). This type of research, emphasizing race and ethnicity as a social construct, can help unravel the mechanisms for observed racial and ethnic disparities (...)
• 02:00
  Childhood Parental Incarceration and Adult-Onset Hypertension and Cardiovascular Risk JAMA Cardiology
  This cohort study examines the association of childhood exposure to parental incarceration with cardiovascular risk among a nationally representative sample of US adults.
• 02:00
  Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events JAMA Cardiology
  This systematic review and meta-regression evaluates the association between coronary plaque regression induced by lipid-lowering therapies and major adverse cardiovascular events.
• 02:00
  Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes JAMA Cardiology
  This cohort study assesses the incremental predictive value of a modified Global Registry of Acute Coronary Events score incorporating high-sensitivity cardiac troponin T at presentation, a surrogate of the extent of myocardial injury.
• 02:00
  Insulin Resistance and N-Terminal Pro-B-Type Natriuretic Peptide Among Healthy Adults JAMA Cardiology
  This cross-sectional study examines the association between insulin resistance and N-terminal pro-B-type natriuretic peptide in adults without diabetes or cardiovascular disease based on body composition measures.
• 02:00
  A Tribute to William C. Roberts, MD, 1932-2023 JAMA Cardiology
  A gentleman in cardiovascular science and medicine is no longer with us. For those of us who shared the moments, the gift, the experience of William “Bill” C. Roberts’ (Figure) company and mentorship, we will always hold special our memories of his wit, precise intellect, plainspoken wisdom, (...)
• 02:00
  Adult With Unrepaired Single-Ventricle Defect JAMA Cardiology
  This case report discusses the diagnosis of double-inlet left ventricle in a male adult patient in his 50s who presented with New York Heart Association class III heart failure.
• 02:00
  Linking Kidney Vessel Scarring to Cardiovascular Risk JAMA Cardiology
  To the Editor In their study of a native kidney biopsy cohort, Buckley et al demonstrate significant associations between histopathologic diagnoses as well as individual lesions and the risk of incident major adverse cardiovascular events during follow-up. These results highlight the relevance (...)
• 02:00
  Errors in Table and Results Section JAMA Cardiology
  In the Brief Report titled “Coronary Venous Pressure and Microvascular Hemodynamics in Patients With Microvascular Angina: A Randomized Clinical Trial,” published online on August 23, 2023, the values for mean aortic and distal coronary pressure where inverted in the Table, as were the values (...)
• 02:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)

1er septembre

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 02:00
  Representation of Race and Ethnicity in the Contemporary US Health Cohort All of Us Research Program JAMA Cardiology
  This cohort study investigates the racial and ethnic diversity of the All of Us Research Program compared with the racial and ethnic diversity of the US population.
• 02:00
  Serial N-Terminal Pro–B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure JAMA Cardiology
  To the Editor Jia et al investigated the associations between 6-year change in N-terminal pro–B-type natriuretic peptide (NT-proBNP) and the risk of heart failure (HF) hospitalization and all-cause death among adults without prior HF, using the data from the Atherosclerosis Risk in Communities (...)
• 02:00
  Serial N-Terminal Pro–B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure—Reply JAMA Cardiology
  In Reply In their letter about our article on change in N-terminal pro–B-type natriuretic peptide (NT-proBNP) and outcomes, Dai and Ohde bring up 2 concerns: (1) they feel that the value of the association between change in NT-proBNP and outcomes was not well substantiated by our data and that (...)
• 02:00
  A Patient in Their 70s With Bright Red Blood in the Pericardiocentesis Catheter JAMA Cardiology
  This case report discusses a finding of blood in the pericardiocentesis catheter of a patient with a recent history of aortic valve replacement and recurrent postsurgical pericardial and pleural effusions.
• 02:00
  Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure JAMA Cardiology
  This cross-sectional study evaluates the associations between leukocyte telomere length and cardiac size, function, and heart failure.
• 02:00
  Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials JAMA Cardiology
  This systematic review analyzes data reported from clinical trials studying treatments for valvular heart disease to determine trends in the representation of older patients, women, and racial and ethnic minority individuals among these trial participants.
• 02:00
  Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping JAMA Cardiology
  This cohort study assesses whether native T1 mapping can measure the cardiac light-chain amyloidosis treatment response and the association between changes in native T1 and prognosis.
• 02:00
  Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis JAMA Cardiology
  Multimodality imaging is at the forefront of advancing our understanding of cardiac amyloidosis. Imaging biomarkers are crucial in comprehending the pathophysiology of amyloidosis, especially as animal models of the disease are unreliable. Cardiac magnetic resonance (CMR) imaging has played a (...)
• 02:00
  Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation JAMA Cardiology
  This secondary analysis of a randomized clinical trial examines whether immediate coronary angiography after out-of-hospital cardiac arrest with a presumed cardiac cause but without ST-segment elevation improves clinical outcomes at 1 year compared with a delayed or selective invasive approach.
• 02:00
  Assisted Reproductive Technologies and Maternal Cardiovascular Disease JAMA Cardiology
  This cohort study assesses the association between use of assisted reproductive technologies and risk of cardiovascular disease among parous women.
• 02:00
  Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy JAMA Cardiology
  This post hoc analysis of the Randomized Comparison of Efficacy and Safety of Lipid Lowering With Statin Monotherapy vs Statin/Ezetimibe Combination for High-Risk Cardiovascular Disease (RACING) randomized clinical trial investigates if a moderate-intensity statin plus ezetimibe combination (...)
• 02:00
  Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence JAMA Cardiology
  Adolescence is a critical period for the prevention of cardiovascular diseases (CVDs). Cardiovascular health (CVH) is a concept introduced in 2010 by the American Heart Association that uses a positive paradigm to measure, monitor, and modify CVD risk. This measurement combines 4 health risk (...)
• 02:00
  School-Based Cardiovascular Health Promotion in Adolescents JAMA Cardiology
  This randomized clinical trial compares the use of school-based health promotion interventions in adolescents in 2- vs 4-year programs, including a control group with the standard curriculum.
• 02:00
  Diversity in Clinical Trial Enrollment and Reporting JAMA Cardiology
  Not everything that is faced can be changed. But nothing can be changed until it is faced.James Baldwin
• 02:00
  Troponins and Pregnancy JAMA Cardiology
  To the Editor We read with great interest the Research Letter by Minhas et al. The authors conclude that “Pregnant women did not have elevated hs-cTn [high-sensitivity cardiac troponin] levels compared with nonpregnant women, …suggesting that pregnancy alone does not result in significant (...)
• 02:00
  Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection JAMA Cardiology
  This combination cohort and case-crossover study evaluates the association between fluoroquinolone use and hospitalization with aortic aneurysm or aortic dissection.
• 02:00
  Adenosine Triphosphate Citrate Lyase and Fatty Acid Synthesis Inhibition JAMA Cardiology
  This Narrative Review assesses adenosine triphosphate citrate lyase inhibition with bempedoic acid as therapy in high-risk patients who require further low-density lipoprotein cholesterol lowering.
• 02:00
  Out-of-Hospital Cardiac Arrest JAMA Cardiology
  Out-of-hospital cardiac arrest (OHCA) is associated with significant mortality, and the most common underlying cause is myocardial infarction. Previously, observational data had suggested a benefit from immediate coronary angiography (CAG) for patients with or without ST-segment elevation (...)
• 02:00
  Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults JAMA Cardiology
  Since the first successful use of in vitro fertilization resulting in a live birth in 1978, use of assisted reproductive technologies (ARTs) for the treatment of infertility has grown exponentially with 2.0% of all live births in the US in 2020 conceived with ART. A variety of ART options are (...)
• 02:00
  Troponins and Pregnancy—Reply JAMA Cardiology
  In Reply We thank Furenäs and Dellborg for their letter and commentary on our article. Recent data show a concerning rise in maternal mortality in the US, with cardiovascular disease the leading cause of nonobstetric death. Cardiac biomarkers, such as N-terminal pro–brain natriuretic peptide (...)
• 02:00
  Error in Figure JAMA Cardiology
  The Original Investigation titled “Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial,” published on August 2, (...)
• 02:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)

1er août

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 02:00
  Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy JAMA Cardiology
  This Viewpoint describes how shared decision-making should be used in patients with aortic stenosis who have a longer life expectancy.
• 02:00
  Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals JAMA Cardiology
  This cohort study estimates age-dependent risks for cardiovascular events with the amyloidogenic pV142I variant.
• 02:00
  Unusual Source of Dysphagia in a Man in His Eighth Decade of Life JAMA Cardiology
  This case report discusses a diagnosis of arteria lusoria in a man with a history of transthyretin cardiac amyloidosis who presented for evaluation of dysphagia and transcatheter aortic valve replacement.
• 02:00
  Mitigating Cardiovascular Disease Risk in Type 2 Diabetes and Chronic Kidney Disease JAMA Cardiology
  In 1836, Sir Richard Bright elegantly described a myriad of structural cardiac changes on the autopsies of patients who had died with shrunken kidneys. These patients were noted to be “secretors of albuminous urine,” perhaps first describing what is recognized now as chronic kidney disease (...)
• 02:00
  Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone JAMA Cardiology
  This subanalysis of the Finerenone in Chronic Kidney Disease and Type 2 Diabetes: Combined FIDELIO-DKD and FIGARO-DKD Trial Programme Analysis (FIDELITY) randomized clinical trial investigates if chronic kidney disease–associated composite cardiovascular risk is modifiable with finerenone in (...)
• 02:00
  Reflections on a Posthumous Existence JAMA Cardiology
  This essay describes the author’s experience after surviving a 40-day in-hospital treatment for septicemia from Staphylococcus endocarditis on a prosthetic aortic valve.
• 02:00
  Assessment of Oxygen Pulse in Hypertrophic Cardiomyopathy JAMA Cardiology
  To the Editor We would like to congratulate Wheeler et al on their current study, which provides important information showing that therapy with mavacamten improved many performance parameters during cardiopulmonary exercise testing in patients with hypertrophic obstructive cardiomyopathy (...)
• 02:00
  Assessment of Oxygen Pulse in Hypertrophic Cardiomyopathy—Reply JAMA Cardiology
  In Reply We would like to thank van der Stouwe et al for their interest and insightful comments related to our recent publication. The results showed that mavacamten treatment was associated with significant improvements in a range of cardiopulmonary exercise testing parameters beyond peak (...)
• 02:00
  Novel Association of the Novel NOTCH Pathway Regulator MIB1 Gene With the Development of Bicuspid Aortic Valve JAMA Cardiology
  This genetic association study investigates the genetic cause for bicuspid aortic valve development.
• 02:00
  Error in Supplement JAMA Cardiology
  The Original Investigation “Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials,” published online February 28, 2023, contained 2 errors in Supplement 3 Nonauthor Collaborators. The name for nonauthor (...)
• 02:00
  Errors in Funding/Support JAMA Cardiology
  The Review titled, “Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review,” published in the March 2022 issue, listed incomplete and inaccurate Funding/Support information for Dr Powe. The Article Information section has been updated to include the (...)
• 02:00
  Evidence Generation for Novel Cardiovascular Devices JAMA Cardiology
  Over the last 50 years, cardiovascular medicine has had a substantial effect on human health through careful and continuous innovation and the application of therapies that have been evaluated in randomized clinical trials, including numerous advances in the care of patients with acute (...)
• 02:00
  Woman in Her 50s With Pulmonary Hypertension Associated With Takayasu Arteritis JAMA Cardiology
  This case report describes a woman diagnosed with Takayasu arteritis after presenting with a 2-month history of dyspnea and pulmonary artery hypertension.
• 02:00
  What Role for New York Heart Association Class in Heart Failure Clinical Trials? JAMA Cardiology
  To the Editor In a recently published secondary analysis of the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) trial, Rohde et al highlight several limitations of the New York Heart Association (NYHA) functional (...)
• 02:00
  Percutaneous Microaxial Left Ventricular Assist Device for Patients With Cardiogenic Shock JAMA Cardiology
  This comparative effectiveness research study compares percutaneous microaxial left ventricular assist device vs alternative treatments among patients presenting with acute myocardial infarction with cardiogenic shock.
• 02:00
  Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome JAMA Cardiology
  This cohort study assesses the association between syncope with different trigger types and subsequent risk of life-threatening events.
• 02:00
  Comments on the myPACE Randomized Clinical Trial JAMA Cardiology
  To the Editor We read with great interest the myPACE study by Infeld et al testing a personalized accelerated pacing heart rate in patients with heart failure (HF) with preserved ejection fraction (HFpEF). Despite the evidence supporting the use of sodium-glucose cotransporter 2 inhibitors in (...)
• 02:00
  Comments on the myPACE Randomized Clinical Trial—Reply JAMA Cardiology
  In Reply We thank Camilli and colleagues for their interest in the myPACE trial. We agree that the reduction in atrial fibrillation (AF) with moderately accelerated pacing in patients with heart failure with preserved ejection fraction (HFpEF) requires further study and confirmation. However, (...)
• 02:00
  Coronary Atherosclerotic Plaque Activity and Future Coronary Events JAMA Cardiology
  This cohort study evaluates whether coronary atherosclerotic plaque activity as assessed by noninvasive imaging is associated with coronary events in patients with myocardial infarction.
• 02:00
  Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation JAMA Cardiology
  This randomized clinical trial compares outcome data from circumferential pulmonary vein isolation treatment in patients aged 65 to 80 years with paroxysmal atrial fibrillation to explore the incremental benefit of additional substrate ablation in patients low-voltage areas.
• 02:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)
• 02:00
  Management of Postpartum Left Main Spontaneous Coronary Artery Dissection JAMA Cardiology
  A woman in her early 40s who was 11 weeks post partum presented with acute pleuritic chest pain, shortness of breath, and nausea that started several hours after arriving on a flight.
• 02:00
  Gauging the Success of Low-Voltage-Area Ablation JAMA Cardiology
  The treatment of atrial fibrillation (AF) has evolved with the development of catheter ablation techniques. Ablation of paroxysmal AF is now standard of care, with accelerating uptake due to the results of recent high-profile randomized clinical trials showing improved outcomes compared with (...)
• 02:00
  Comments on the myPACE Randomized Clinical Trial JAMA Cardiology
  To the Editor We read with great interest the results of the myPACE randomized clinical trial. In this article, patients with heart failure with preserved ejection fraction were randomly assigned to personalized accelerated pacing or usual care and were followed up for 1 year. This resulted in (...)

1er juillet

JAMA Cardiology https://jamanetwork.com/journals/jamacardiology

• 02:00
  Titanium-Nitride-Oxide–Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome JAMA Cardiology
  This randomized clinical trial compares the rate of main composite outcome of cardiac death, myocardial infarction, or ischemia-driven target lesion revascularization at 5 years in patients with acute coronary syndromes.
• 02:00
  Dapagliflozin vs Placebo and Individual KCCQ Components in Patients With HF JAMA Cardiology
  This secondary analysis of a randomized clinical trial evaluates the association between treatment with dapagliflozin vs placebo and improvement in components of the Kansas City Cardiomyopathy Questionnaire.
• 02:00
  Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction JAMA Cardiology
  This post hoc analysis of a randomized clinical trial evaluates the safety and efficacy of empagliflozin in patients with heart failure and preserved ejection fraction who are taking diuretics.
• 02:00
  Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among US Patients Hospitalized for HFrEF JAMA Cardiology
  This cohort study characterizes patterns of sodium-glucose cotransporter-2 inhibitor use among eligible patients hospitalized for heart failure with reduced ejection fraction (HFrEF).
• 02:00
  Explanation of Error in the Clinical Challenge, “A Case of Right Bundle Branch Block With Changing Axis” JAMA Cardiology
  To the Editor We write to explain an error that occurred in our Clinical Challenge, “A Case of Right Bundle Branch Block With Changing Axis,” published online November 30, 2022, and in the February issue of JAMA Cardiology. The article features a patient with right bundle branch block (RBBB) (...)
• 02:00
  Cardiovascular Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure—Does the Story Begin and End With the Kidney? JAMA Cardiology
  Sodium-glucose cotransporter 2 (SGLT2) is primarily expressed in the proximal convoluted tubules of the kidney and, in a sodium-dependent manner, reabsorbs 90% of glucose that is filtered from the glomerulus. In heart failure with preserved ejection fraction (HFpEF), pharmacologic blockade of (...)
• 02:00
  A Man Aged 45 Years With Chinese Dragon Sign on Chest Radiography JAMA Cardiology
  This case report discusses a diagnosis of acute systolic heart failure in a man aged 45 years with multiple radiographic findings, including the Chinese dragon sign.
• 02:00
  When Is a High Lipoprotein (a) Concentration Too High?—The Need for Diverse Population-Based Samples JAMA Cardiology
  Preclinical, epidemiologic, and genomic studies identify lipoprotein (a) (Lp[a]) as a risk factor for atherosclerotic cardiovascular disease (ASCVD). Lp(a) is a low-density lipoprotein (LDL)–like particle that is bound to apolipoprotein(a) and is causally implicated in the pathogenesis of (...)
• 02:00
  Error in Diagnosis and Text JAMA Cardiology
  In the Clinical Challenge titled “A Case of Right Bundle Branch Block With Changing Axis,” published online November 30, 2022, and in the February 2023 issue, there was an error in the diagnosis caused by reversal of leads aVF and aVL on the 2 electrocardiograms. The text was updated to (...)
• 02:00
  Heterogeneity of Lipoprotein(a) Levels Among Hispanic or Latino Individuals Residing in the US JAMA Cardiology
  This cohort study investigates the distribution of lipoprotein(a) levels among Hispanic or Latino individuals residing in the US.
• 02:00
  Error in Figure JAMA Cardiology
  The Original Investigation titled “Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020,” published on March 22, 2023, was (...)
• 02:00
  PCI vs CABG for Left Main Disease in Patients With and Without ACS JAMA Cardiology
  This pooled analysis includes data from 4 major randomized clinical trials that compare PCI with drug-eluting stents vs CABG to assess differences in outcomes for patients with left main coronary artery disease with and without acute coronary syndrome.
• 02:00
  Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy–Related Cardiac Dysfunction JAMA Cardiology
  This cohort study analyzes biomarker data for patients with ERBB2-positive breast cancer to determine the association between circulating cardiomyocyte cell-free DNA and subsequent cancer therapy–related cardiac dysfunction after anthracycline chemotherapy and ERBB2-targeted therapy.
• 02:00
  Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw JAMA Cardiology
  This Viewpoint describes the advantages of measuring a lipid panel before cardiac catheterization to optimize lipid-lowering therapy.
• 02:00
  Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy JAMA Cardiology
  This genome-wide association study seeks to identify genetic risk factors associated with preeclampsia and hypertensive disorders in pregnancy.
• 02:00
  Value of Stress Cardiovascular Magnetic Resonance Imaging in Coronary Artery Disease JAMA Cardiology
  This systematic review and meta-analysis assesses the diagnostic accuracy and prognostic value of stress cardiovascular magnetic resonance imaging in patients with stable chest pain and known or suspected coronary artery disease.
• 02:00
  JAMA Cardiology JAMA Cardiology
  Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (...)